Inositols' Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS.
Anna WojciechowskaAdam OsowskiMarcin JóźwikRyszard GóreckiAndrzej RynkiewiczWojtkiewicz JoannaPublished in: International journal of molecular sciences (2019)
Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility and metabolic problems among women of reproductive age. The mechanism of PCOS is associated with concurrent alterations at the hormonal level. The diagnosis assumes the occurrence of three interrelated symptoms of varying severity, namely ovulation disorders, androgen excess, or polycystic ovarian morphology (PCOM), which all require a proper therapeutic approach. The main symptom seems to be an increased androgen concentration, which in turn may contribute to different metabolic disorders. A number of papers have demonstrated the significant role of inositol therapy in PCOS. However, there is a lack of detailed discussion about the importance of myo-inositol (MI) and d-chiro-inositol (DCI) in reference to particular symptoms. Thus, the aim of this review is to present the effectiveness of MI and DCI treatment for PCOS symptoms. Moreover, the review is focused on analyzing the use of inositols, taking into account their physiological properties, together with the mechanism of individual PCOS symptom formation.
Keyphrases
- polycystic ovary syndrome
- insulin resistance
- mental health
- sleep quality
- type diabetes
- risk assessment
- squamous cell carcinoma
- adipose tissue
- systematic review
- skeletal muscle
- pregnant women
- stem cells
- physical activity
- patient reported
- radiation therapy
- sensitive detection
- rectal cancer
- locally advanced
- cell therapy
- single molecule